Vericel officer Jonathan Siegal sells 1,500 shares

Q: What options did Vericel Corp's Principal Accounting Officer exercise?

Jonathan Siegal exercised options for 1,500 common shares at an exercise price of $34.90 per share on November 5, 2026. The reported options afterward covered 1,198 shares and had an expiration date of February 18, 2032.

After the exercise, the reported options covered 1,198 shares and had an expiration date of February 18, 2032.

Available on EDGAR 11/06/2026 - 04:06 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:05 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Vericel Corp Principal Accounting Officer Jonathan Siegal exercised options to acquire 1,500 shares of common stock on November 5, 2026, at an exercise price of $34.90 per share, then sold 1,500 shares at $52.90 per share. The sale was automatic under a Rule 10b5-1 trading plan adopted December 10, 2025.

Insider Trade Summary 10b5-1

Exercise and Sale: 1,500 shares ($27K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider SIEGAL JONATHAN

Role Principal Accounting Officer

Sold 1,500 shs ($79K)

Approx. gross sale proceeds $79K

Approx. exercise cost $52K

Approx. pre-tax spread $27K

Share of Position Sold 54.4%

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F3	1,500	$0.00	$0.00
Exercise	Common Stock ^F1	1,500	$34.90	$52K
Sale	Common Stock ^{F2, F1}	1,500	$52.90	$79K

Holdings After Transaction: Stock Option (Right to Buy) — 1,198 contracts (Direct); Common Stock — 1,259 shares (Direct)

Holdings Before and After: Common Stock, 1,259 to 1,259 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (3)

F1. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
F3. These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted

Key Figures

Option shares exercised: 1,500 shares Exercise price: $34.90 per share Common shares sold: 1,500 shares +3 more

6 metrics

Option shares exercised 1,500 shares November 5, 2026

Exercise price $34.90 per share Option exercise on November 5, 2026

Common shares sold 1,500 shares November 5, 2026

Sale price $52.90 per share Sale on November 5, 2026

Shares covered by reported options after exercise 1,198 shares Reported after the November 5, 2026 transaction

Option expiration date February 18, 2032 Reported options

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy), vesting

3 terms

Rule 10b5-1 trading plan regulatory

"automatic sale pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

vesting financial

"first vesting date on May 18, 2022"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VCEL shares did Jonathan Siegal sell?

Jonathan Siegal, Vericel Corp's Principal Accounting Officer, sold 1,500 shares at $52.90 per share on November 5, 2026. The sale was effected automatically under a Rule 10b5-1 trading plan adopted December 10, 2025.

What options did Vericel Corp's Principal Accounting Officer exercise?

Jonathan Siegal exercised options for 1,500 common shares at an exercise price of $34.90 per share on November 5, 2026. The reported options afterward covered 1,198 shares and had an expiration date of February 18, 2032.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SIEGAL JONATHAN

(Last)

(First)

(Middle)

25 BLUE SKY DRIVE

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Principal Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/05/2026		M		1,500	A	$34.9	2,759⁽¹⁾	D
Common Stock	11/05/2026		S		1,500	D⁽²⁾	$52.9	1,259⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$34.9	11/05/2026		M		1,500		⁽³⁾	02/18/2032	Common Stock	1,500	$0	1,198	D

Explanation of Responses:

1. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

2. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

3. These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted

	/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Siegal	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR